CVS To Pay $5M To End FTC's Deceptive Drug Price Claims
Under the terms of the settlement, CVS is barred from misrepresenting drug prices in the future, according to the agreement. The $5 million will be deposited into a fund that will reimburse eligible consumers who were harmed by the inaccurate prices.
"This settlement puts money...
To view the full article, register now.